inactivated vaccine – Asian Pacific Journal of Allergy and Immunology

HOME
ABOUT
EDITORS
SUBMISSION
- Online Submission
- Author Instructions
ISSUE
PERMISSIONS
CONTACT
ADVERTISE

inactivated vaccine

October 25, 2022

Disease activity of patients with chronic urticaria receiving COVID-19 vaccines

Cutaneous adverse events after receiving a COVID-19 vaccine were identified. The disease activity of urticaria after a COVID-19 vaccine has never been explored in chronic urticaria patients.

adenovirus-based vaccine, Chronic Urticaria, COVID-19 vaccination, disease activity, inactivated vaccine

Key words

Adherence allergen Allergic rhinitis Allergy Anaphylaxis anxiety Asthma atopic dermatitis child Children Chlorhexidine chronic rhinosinusitis chronic spontaneous urticaria Chronic Urticaria COVID-19 cytokine depression drug allergy Drug hypersensitivity efficacy Epidemiology food allergy house dust mite hypersensitivity IgE Immunotherapy obstructive sleep apnea Omalizumab prevalence primary immunodeficiency Quality of life Questionnaire Reliability risk factor risk factors safety SARS-CoV-2 Sensitization Severe asthma Skin prick test Specific IgE Thai treatment urticaria vaccine

Support Contact

Managing Editor
Ms. Patrawadee Pitakpolrat
E-mail: managingeditor@apjai-journal.org

Production Editor
Ms. Chanita Jangsawang
E-mail: chanita.j@apjai-journal.org